<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03064503</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL15_0744</org_study_id>
    <nct_id>NCT03064503</nct_id>
  </id_info>
  <brief_title>Myocardial Fibrosis, Function and Aging</brief_title>
  <acronym>MARVEL</acronym>
  <official_title>Myocardial Fibrosis and Changes of Myocardial Function Related to Aging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In normal ageing, the impact of myocardial fibrosis on myocardial function is unclear as
      diastolic function is reported to change according to age. The objective is to explore the
      relationship between myocardial function changes, with local (T1 and diffusion) fibrosis
      measures with Magnetic Resonance Imaging (MRI) as well as global measures of fibrosis (skin
      auto-fluorescence and collagen blood-biomarkers).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Regional myocardial strain</measure>
    <time_frame>The day of MRI</time_frame>
    <description>Segmental measures of systolic and diastolic strains with magnetic resonance imaging (MRI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRI T1 value</measure>
    <time_frame>The day of MRI, before gadolinium injection</time_frame>
    <description>This value is an indicator of interstitial fibrosis and extracellular volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI T1 value</measure>
    <time_frame>The day of MRI, 15 minutes after gadolinium injection</time_frame>
    <description>Diminution of this value after gadolinium injection is an indicator of increasing quantity of interstitial fibrosis and extracellular volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apparent Diffusion Coefficient (ADC) with MRI</measure>
    <time_frame>The day of MRI</time_frame>
    <description>ADC is measured with diffusion weighted imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood carboxy-terminal propeptide of procollagen type I (PICP) rate</measure>
    <time_frame>The day of MRI</time_frame>
    <description>Collagen blood biomarker analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood amino-terminal propeptide of procollagen type III (PIIINP) rate</measure>
    <time_frame>The day of MRI</time_frame>
    <description>Collagen blood biomarker analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Advanced Glycation End-products (AGE) rate</measure>
    <time_frame>The day of MRI</time_frame>
    <description>Skin auto-fluorescence AGE measures</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedentary healthy subjects will be recruited in this study. MRI, skin auto-fluorescence measures and blood sampling will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Blood sampling will be performed at inclusion to investigate some biological eligibility criteria, and the day of MRI in order to analyse fibrosis biomarkers and collagen synthesis biomarkers</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI will be performed to measure interstitial fibrosis</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Skin auto-fluorescence</intervention_name>
    <description>Skin auto-fluorescence measures will be performed to measure advanced glycation end-products (AGE) produced by collagen degradation</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  physical activity ≤ 3 x(30') per week

          -  no history of smoking, diabetes, myocardial infarction, heart failure, hypertension
             (&lt;140 or &lt;90 mmHg) and no anti-hypertensive or cardiovascular-related medications

          -  no familial history of early myocardial ischemia

          -  body mass index (BMI) &lt;30kg/m2

          -  normal routine lipid blood analysis

          -  glycemia &lt;1.26g/l

          -  normal electrocardiogram (ECG)

        Exclusion Criteria:

          -  arrhythmia

          -  hepatic insufficiency

          -  pregnancy

          -  claustrophobia

          -  MRI contrast allergy,

          -  general contraindications to MRI such as pacemaker, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre CROISILLE, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Saint-Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre CROISILLE, MD, PhD</last_name>
    <phone>+33 477 127 584</phone>
    <email>croisille@creatis.insa-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Département de Radiologie, CHU Saint-Etienne - Hôpital Nord</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre CROISILLE, MD, PhD</last_name>
      <phone>+33 477 127 584</phone>
      <email>croisille@creatis.insa-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre CROISILLE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2017</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2017</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>myocardial fibrosis</keyword>
  <keyword>cardiac function</keyword>
  <keyword>ageing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

